Advanced Connection Corporation Public Company Limited (“the Company”) has received financial relief from the company and subsidiaries for 6 months approval for the second quarter of 2019 ended 30 June 2019
. TorChor. 72/2558 (2015) Re: Approval for Listed Companies to Offer Newly Issued Shares to Specific Investors (Private Placement). In addition, the offering of the newly issued ordinary shares to Silom Road
Securities Public Company Limited (the “Company”) hereby informs that the Board of Directors’ Meeting No. 8/2018, held on November 12, 2018, has resolved to grant approval for the Company to dispose of the
, 2019. And request approval from the Board of Directors. Thus, this transaction must be revealed to the SET following the detail : Purchase of machinery, molds and equipment Agreement Parties Involved
Transactions B.E.2546 (“Notification of Connected Transaction”), are considered a medium size at 1.10% of NTA. Therefore, the Company is required to obtain the approval from the Board of Directors and to
Companies concerni ng connected transactions B.E.2546. KYE must take following actions:- • Seek approval from the Board of Directors' meeting. • Report and disclosure of information of this transaction to the
Companies conce rning connected transactions B.E.2546. KYE must take following actions:- • Seek approval from the Board of Directors' meeting. • Report and disclosure of information of this transaction to the
Advanced Connection Corporation Public Company Limited (“the Company”) has received financial relief from the company and subsidiaries for 9 months approval for the quarter 3/2019 ended 30 September 2019. It
:- • Seek approval from the Board of Directors' meeting. • Report and disclosure of information of this transaction to the SET The Transaction is deemed to be an acquisition of assets pursuant to the
Limited (“INGRS”) would like to inform that on 11th November 2019, INGRS via its subsidiary company, Ingress Industrial (Malsysia) Sdn Bhd (“IIM”) received the approval from the Minister of Law and Human